20b91956d3b6c77f…

{
  "id": "NCT00099710",
  "type": "Study",
  "data": {
    "briefSummary": "The purpose of this study is to examine the safety and tolerability of curcumin, and to determine its effect on patients with mild to moderate Alzheimer's Disease (AD).",
    "completionDate": "2007-12",
    "conditions": [
      "Alzheimer's Disease"
    ],
    "enrollmentCount": 33,
    "enrollmentType": "ESTIMATED",
    "nctId": "NCT00099710",
    "phase": "PHASE2",
    "sponsorId": "john-douglas-french-foundation",
    "startDate": "2003-07",
    "status": "COMPLETED",
    "studyType": "INTERVENTIONAL",
    "title": "A Phase II, Double-Blind, Placebo-Controlled Study of the Safety and Tolerability of Two Doses of Curcumin C3 Complex Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease",
    "url": "https://clinicaltrials.gov/study/NCT00099710"
  }
}